Cite

HARVARD Citation

    Torii, H. et al. (2013). Dermatological side‐effects of telaprevir‐based triple therapy for chronic hepatitis C in phase III trials in Japan. Journal of dermatology. 40 (8), pp. 587-595. [Online]. 
  
Back to record